KDM2B
Lysine-specific demethylase 2B
Also known as: CXXC2, Fbl10, FBXL10, JHDM1B, KDM2B_HUMAN, PCCX2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NHM5
- Gene
- KDM2B
- Ensembl
- ENSG00000089094
- Chromosome
- 12
- Canonical length
- 1336 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
This gene encodes a member of the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbls class. Multiple alternatively spliced transcript variants have been found for this gene, but the full-length nature of some variants has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1336 residues, UniProt reviewed canonical sequence.
>Q8NHM5|KDM2B
1 MAGPQMGGSA EDHPPRKRHA AEKQKKKTVI YTKCFEFESA TQRPIDRQRY DENEDLSDVE
61 EIVSVRGFSL EEKLRSQLYQ GDFVHAMEGK DFNYEYVQRE ALRVPLIFRE KDGLGIKMPD
121 PDFTVRDVKL LVGSRRLVDV MDVNTQKGTE MSMSQFVRYY ETPEAQRDKL YNVISLEFSH
181 TKLEHLVKRP TVVDLVDWVD NMWPQHLKEK QTEATNAIAE MKYPKVKKYC LMSVKGCFTD
241 FHIDFGGTSV WYHVFRGGKI FWLIPPTLHN LALYEEWVLS GKQSDIFLGD RVERCQRIEL
301 KQGYTFFIPS GWIHAVYTPV DSLVFGGNIL HSFNVPMQLR IYEIEDRTRV QPKFRYPFYY
361 EMCWYVLERY VYCVTQRSHL TQEYQRESML IDAPRKPSID GFSSDSWLEM EEEACDQQPQ
421 EEEEKDEEGE GRDRAPKPPT DGSTSPTSTP SEDQEALGKK PKAPALRFLK RTLSNESEES
481 VKSTTLAVDY PKTPTGSPAT EVSAKWTHLT EFELKGLKAL VEKLESLPEN KKCVPEGIED
541 PQALLEGVKN VLKEHADDDP SLAITGVPVV TWPKKTPKNR AVGRPKGKLG PASAVKLAAN
601 RTTAGARRRR TRCRKCEACL RTECGECHFC KDMKKFGGPG RMKQSCIMRQ CIAPVLPHTA
661 VCLVCGEAGK EDTVEEEEGK FNLMLMECSI CNEIIHPGCL KIKESEGVVN DELPNCWECP
721 KCNHAGKTGK QKRGPGFKYA SNLPGSLLKE QKMNRDNKEG QEPAKRRSEC EEAPRRRSDE
781 HSKKVPPDGL LRRKSDDVHL RKKRKYEKPQ ELSGRKRASS LQTSPGSSSH LSPRPPLGSS
841 LSPWWRSSLT YFQQQLKPGK EDKLFRKKRR SWKNAEDRMA LANKPLRRFK QEPEDELPEA
901 PPKTRESDHS RSSSPTAGPS TEGAEGPEEK KKVKMRRKRR LPNKELSREL SKELNHEIQR
961 TENSLANENQ QPIKSEPESE GEEPKRPPGI CERPHRFSKG LNGTPRELRH QLGPSLRSPP
1021 RVISRPPPSV SPPKCIQMER HVIRPPPISP PPDSLPLDDG AAHVMHREVW MAVFSYLSHQ
1081 DLCVCMRVCR TWNRWCCDKR LWTRIDLNHC KSITPLMLSG IIRRQPVSLD LSWTNISKKQ
1141 LSWLINRLPG LRDLVLSGCS WIAVSALCSS SCPLLRTLDV QWVEGLKDAQ MRDLLSPPTD
1201 NRPGQMDNRS KLRNIVELRL AGLDITDASL RLIIRHMPLL SKLHLSYCNH VTDQSINLLT
1261 AVGTTTRDSL TEINLSDCNK VTDQCLSFFK RCGNICHIDL RYCKQVTKEG CEQFIAEMSV
1321 SVQFGQVEEK LLQKLSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KDM2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 22 nTPM
Expression across tissuesHPA
Tissue
- skin: 22 nTPM
- thymus: 22 nTPM
- lymph node: 21 nTPM
- tonsil: 20 nTPM
- cerebellum: 19 nTPM
- appendix: 18 nTPM
Single-cell type
- cdc: 228 nCPM
- nk-cells: 148 nCPM
- myonuclei: 147 nCPM
- b-cells: 143 nCPM
- t-cells: 126 nCPM
- retinal bipolar cells: 123 nCPM
Immune cell
- memory B-cell: 9.5 nTPM
- naive B-cell: 9.4 nTPM
- gdT-cell: 6.3 nTPM
- naive CD8 T-cell: 5.8 nTPM
- MAIT T-cell: 4.9 nTPM
- memory CD4 T-cell: 4.9 nTPM
Brain region
- cerebellum: 36 nTPM
- cerebral cortex: 30 nTPM
- pons: 28 nTPM
- white matter: 27 nTPM
- basal ganglia: 27 nTPM
- medulla oblongata: 26 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KDM2B.
Disease | GeneticClinVar
19 pathogenic / likely-pathogenic of 336 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with congenital cardiac defects and variable renal and ocular abnormalities
- KDM2B-related disorder
- Inborn genetic diseases
- KDM2B-related syndrome
Disease | ImmuneIEDB
Conditions an epitope on KDM2B was assayed in.
- narcolepsy B cell
- multiple sclerosis B cell
- peripheral nervous system disease B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.18
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.44
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chromatin remodeling
- embryonic camera-type eye morphogenesis
- forebrain development
- fourth ventricle development
- hindbrain development
- lateral ventricle development
- midbrain development
- midbrain-hindbrain boundary morphogenesis
- negative regulation of neural precursor cell proliferation
- negative regulation of neuron apoptotic process
- negative regulation of transcription by RNA polymerase II
- positive regulation of cell growth
- positive regulation of stem cell population maintenance
- regulation of transcription by RNA polymerase II
- spermatogenesis
- third ventricle development
- initiation of neural tube closure
Molecular functions
- DNA binding
- histone demethylase activity
- histone H3K36 demethylase activity
- histone H3K36me/H3K36me2 demethylase activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- rRNA binding
- transcription coregulator activity
- unmethylated CpG binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- F-box domain
- Zinc finger, PHD-type
- Zinc finger, CXXC-type
- JmjC domain
- Leucine-rich repeat, cysteine-containing subtype
- Zinc finger, FYVE/PHD-type
- Zinc finger, RING/FYVE/PHD-type
- Zinc finger, PHD-finger
- Leucine-rich repeat domain superfamily
- Jumonji, helical domain
- Cupin-like domain 8
- JHDM1 Histone Demethylase
- F-box/LRR-repeat protein 15-like, leucin rich repeat domain
- CXXC zinc finger domain
- F-box-like
- Cupin-like domain
- PHD-finger
- Jumonji helical domain
- F-box/LRR-repeat protein 15, leucine rich repeat domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KDM2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KDM2B as an antibody target. Whether an autoantibody or antibody against KDM2B could matter depends on whether native KDM2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KDM2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label KDM2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...